Searching…
Join our talent community Explore a new career opportunity with us Improving patients' health across the world through scientific innovation Check Almirall's solutions portfolio.
Almirall, LLC is a global dermatology pharmaceutical company headquartered in Barcelona. For nearly 80 years, we’ve pioneered and launched medicines in over 70 countries.
Almirall ... Almirall, S.A. is a Spanish pharmaceutical company dedicated to medical dermatology, with headquarters in Barcelona, founded in 1944. [5] In 2023, the company generated total revenues of €898.8 [6] millio...
2 days ago · Christopher Bunick, MD, PhD, and Almirall's Johnny Im discuss new data showing that tirbanibulin 1% ointment provides consistent efficacy, while expanded coverage is poised to improve patient access in the US.
2 days ago · ALM | Complete Almirall S.A. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
6 days ago · Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, today presented positive long-term interim results from the ongoing ...
1 day ago · Almirall, S.A. recently reported positive long-term interim Phase 3b ADlong results for lebrikizumab in moderate-to-severe atopic dermatitis, showing sustained efficacy and a consistent safety profile over...
